Cinven seeks continuation fund deal for Dutch life sciences distributor
The firm had considered running a process on the same portfolio company at the end of last year, Secondaries Investor has learned.
SECONDARIES INVESTOR
Register to unlock this content
Daily global secondaries market news and intelligence
Curated insights to keep you ahead of GP-led and LP-led secondaries
Faster, data-driven decision making powered by our AI interface, 'Ask PEI'
Access to proprietary research and reports
Selected fund performance and investor activity data






